TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
107
|
73
|
48 |
| Financial expenses |
38
|
40
|
0 |
| Earnings before taxes |
8
|
6
|
-9 |
| EBITDA |
46
|
45
|
-11 |
| Total assets |
1,276
|
1,418
|
1,508 |
| Current assets |
99
|
88
|
69 |
| Current liabilities |
33
|
25
|
16 |
| Equity capital |
1,234
|
1,381
|
1,479 |
| - share capital |
8
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
96.7%
|
97.4%
|
98.1% |
| Turnover per employee |
107
|
73
|
48 |
| Profit as a percentage of turnover |
7.5%
|
8.2%
|
-18.8% |
| Return on assets (ROA) |
3.6%
|
3.2%
|
-0.6% |
| Current ratio |
300%
|
352.0%
|
431.2% |
| Return on equity (ROE) |
0.6%
|
0.4%
|
-0.6% |
| Change turnover |
41
|
28
|
-12 |
| Change turnover % |
62%
|
61%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.